Tissue engineering aims at resolving problems such as donor shortage and immune rejection faced by transplantation. Scaffolds (artificial extracellular matrices) have critical roles in tissue engineering. Recently, we developed nano-fibrous poly(l-lactic acid) scaffolds under the hypothesis that synthetic nano-fibrous scaffolding, mimicking the structure of natural collagen fibers, could create a more favorable microenvironment for cells. This is the first report that the nano-fibrous architecture built in three-dimensional scaffolds improved the features of protein adsorption, which mediates cell interactions with scaffolds. Scaffolds with nano-fibrous pore walls adsorbed four times more serum proteins than scaffolds with solid pore walls. More interestingly, the nano-fibrous architecture selectively enhanced protein adsorption including fibronectin and vitronectin, even though both scaffolds were made from the same poly(l-lactic acid) material. Furthermore, nano-fibrous scaffolds also allowed Ͼ1.7 times of osteoblastic cell attachment than scaffolds with solid pore walls. These results demonstrate that the biomimetic nano-fibrous architecture serves as superior scaffolding for tissue engineering.
INTRODUCTION
Tissue engineering is a promising approach to resolve the problems faced by transplantation including the shortage of donor tissues (organs) and immune rejection. 1, 2 In tissue engineering, the scaffold [artificial extracellular matrix (ECM)] has critical roles in supporting cell adhesion, migration, proliferation, differentiated function, neo tissue generation, and its three-dimensional (3D) organization. The scaffold is a 3D substrate for cells, serves as a template for tissue regeneration, and should finally be replaced by the cell-produced ECM. To perform these roles, a scaffold should provide a good 3D microenvironment for cell attachment, proliferation, and differentiation. Biodegradable polymers are attractive candidates because they degrade after fulfilling the scaffolding function, eventually leaving nothing foreign in the body.
Collagen is the major component of mammalian connective tissues. It is found in every major tissue that requires strength and flexibility such as bone and skin. Collagen proteins, by definition, are characterized by unique triple-helix formation extending over a large portion of the molecules. So far, approximately 25 distinct collagen alpha chains have been identified, each encoded by a separate gene. 3 The most abundant is type I. The feature of type I collagen molecule is its long, stiff, triple-stranded helical structure, in which three collagen polypeptide chains are wound around one another in a ropelike superhelix. After being secreted into extracellular space, these collagen molecules assemble into higher-order polymers called collagen fibrils, and the fibrils are finally assembled into collagen fibers with diameters ranging from 50 to 500 nm. Being a major ECM component, type I collagen has been used extensively in the formulation of biomedical materials, especially for soft tissue repair. 4 Because of its phylogenetically well-conserved primary sequence and its helical structure, collagen is relatively bioinert. 5 The use of collagen as a scaffold-ing material, however, still remains to be developed to overcome the concern of pathogen transmission, the difficulties in handling, and less control over the mechanical properties, biodegradability, and batch-to-batch consistency of natural materials from biological sources. 6 One of the major goals of tissue engineering is to generate tissues/organs mimicking their natural counterparts. One of the best approaches toward "ideal" scaffold design is the biomimetic methodology. The fiber structure of collagen has long been noticed to be important for cell attachment, proliferation, and differentiated function in tissue culture. [7] [8] [9] We hypothesized that synthetic nano-fibrous architecture could mimic the ECM microenvironment. Under this hypothesis, nano-fibrous materials were developed of synthetic biodegradable polymers in our laboratory using a phase-separation technique, to mimic the architecture of collagen. 6 Moreover, 3D macroporous architectures have been built in the nano-fibrous matrices to improve the cell seeding, distribution, and mass transport. 10 In this work, we report nano-fibrous poly(l-lactic acid) (PLLA) scaffolds with interconnected spherical macropores for tissue engineering applications.
Cell attachment, migration, and growth on the polymer surfaces are believed to be mediated by proteins, either adsorbed from serum proteins or secreted by the cells. To evaluate one of the biological properties of the scaffolds, the protein adsorption to these nanofibrous PLLA scaffolds was examined. Cell attachment in relation to the scaffold architecture was also evaluated.
MATERIALS AND METHODS

Construction of PLLA nano-fibrous polymer scaffolds
A 12.5% (wt/v) solution of PLLA in a 1:1 (v/v) mixture of dioxane and pyridine was prepared. Paraffin spheres (0.40 Ϯ 0.01 g, diameter ϭ 250 -420 m) were added to Teflon molds (cylindrical vial with a diameter of 18 mm), and the top surface of the paraffin was leveled. 11 The molds were then heat-treated at 37°C for 45 min at which time they were removed and cooled to room temperature. Prepared polymer solution (0.32 mL) was cast onto each paraffin sphere assembly dropwise and vacuum-treated quickly in a heated vacuum oven (250 mmHg, ϳ37°C) to remove air trapped inside the paraffin sphere assemblies. Vacuum treatment in the heated oven was done as quickly as possible to avoid further bonding of the paraffin spheres. The polymer solution (in the paraffin assembly) was phase-separated at Ϫ70°C overnight. Then, the vials containing the polymer/ paraffin composite were immersed into cold hexane for 2 days (Ϫ18°C) to extract the solvent. Next, the composites were removed from the vials and were cut to the correct height (1 mm) and diameter (7.2 mm). The composites were then placed into room temperature hexane to extract the remaining solvent and to leach the paraffin from the composite. Samples were kept in room temperature hexane for 2 days, changing the hexane three times a day. Hexane was then exchanged with cyclohexane. The polymer scaffolds were removed from the cyclohexane, and were frozen (Ϫ70°C) for at least 6 h. The frozen scaffolds were then lyophilized (Ͻ30 mmHg) at Ϫ70°C for 7 days, at Ϫ5°to Ϫ10°C for 2 days, and dried under the same vacuum pressure at room temperature for 2 days.
Construction of PLLA solid-walled scaffolds
For PLLA solid-walled scaffolds, a 12.5% (wt/v) solution of PLLA in dioxane was prepared. The paraffin sphere mold preparation and the polymer casting procedure were performed in the same way as for the nano-fibrous scaffolds. After polymer casting, the polymer/paraffin composites were dried under low vacuum overnight (Ϸ340 mmHg), and under high vacuum (Ͻ30 mmHg) for 4 days. Samples were removed from the vials and cut to the correct height (1 mm) and diameter (7.2 mm). Paraffin leaching and lyophilizing procedures were performed in the same manner as for nano-fibrous scaffolds.
Protein adsorption to scaffolds
The scaffolds were placed in the protein solutions after they were completely wetted. To wet the scaffolds, they were soaked in 100% ethanol for an hour and in phosphatebuffered saline (PBS) (Gibco BRL, Grand Island, NY) for 30 min twice. During the wetting procedure, they were placed in a vacuum container to remove air bubbles in the scaffolds. The scaffolds were then incubated in PBS overnight on a shaker (25 rpm). The wetted scaffolds were incubated in 25% human serum, 100 g/mL fibronectin (Sigma, St. Louis, MO), vitronectin (Biosource International, Carmarillo, CA), laminin (Sigma), or bovine serum albumin solutions in PBS for 4 h on the shaker (25 rpm). After the 4 h of incubation, the scaffold was removed from the protein solution, tapped on the Whatman paper, and then transferred to a microtube. The scaffold was washed with 600 L of PBS under gentle agitation for 5 min. The washing solution was then discarded and 600 L of fresh PBS was replaced to wash again. A total of three washings was conducted to remove free and loosely adsorbed proteins (there was a negligible amount of proteins in the third washing solution). The remaining proteins (adsorbed) on the scaffold were recovered by incubation in 1% sodium dodecyl sulfate (SDS) solution for 1 h after homogenization. The procedures were repeated two more times and the three solutions were pooled in one tube. The total amount of protein was measured using MicroBCA assay (Pierce, Rockford, IL).
Western blot analysis for serum fibronectin and vitronectin adsorbed to the scaffolds
The recovered serum protein samples (25 L of a total of 400 L) were subject to fractionation through 4 -12% SDS-polyacrylamide gel electrophoresis (PAGE). The fractionated proteins were transferred to a PVDF membrane (Sigma). The blots were washed with TBST (10 mM TrisHCl, 150 mM NaCl, 0.05% Tween-20, pH 8.0), and blocked with Blotto (5% nonfat milk in TBST) at room temperature for 1 h. The blots were incubated in anti-human fibronectin or anti-human vitronectin polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature for 1 h. After washing with TBST, the blots were incubated in antigoat immunoglobulin G-horseradish peroxidase-conjugated antibody (Sigma), and then in chemiluminescence reagent (SuperSignal West Dura; Pierce). The relative densities of the protein bands were analyzed with QualityOne (Biorad).
Attachment of MC3T3-E1 cells to the scaffolds
The MC3T3-E1 osteoblasts were cultured in ascorbic acidfree alpha-Eagle's minimum essential medium (Quality Biological, Gaithersburg, MD) supplemented with 10% fetal bovine serum (Gibco BRL), 50 U/mL penicillin, and 50 g/mL streptomycin in a humidified incubator at 37°C with a CO 2 /air ratio of 5:95. The sterilized solid-walled and nano-fibrous PLLA scaffolds were soaked in ethanol for 1 h and then exchanged with PBS three times (30 min each). The scaffolds were then washed with the alpha-Eagle's minimum essential medium containing 10% fetal bovine serum two times (2 h each). Two million cells were seeded on each scaffold. The cell-scaffold constructs were cultured on an orbital shaker (75 rpm). After 24 h, the cultured osteoblast-scaffold constructs were washed with PBS twice (5 min each), and homogenized with tissue tearer for 1 min at 20,000 rpm. The DNA content was determined using Hoechst 33258.
Statistical analysis
Student t test was performed, and the difference was regarded as significant if the p value was Ͻ0.05.
RESULTS
Construction of nano-fibrous and solid-walled PLLA scaffolds
Three-dimensional porous PLLA scaffolds (height ϭ 1 mm, diameter ϭ 7.2 mm) were created with interconnected spherical pores (diameter ϭ 250 -420 m). In these studies, the effects of pore wall architectures were compared. Scaffolds having pore walls with nano-fibrous architectures (diameter of fibers Ϸ50 -500 nm) were created by thermally induced phase separation [ Fig. 1(a,b) ], and scaffolds having solid pore walls were created by solvent casting-evaporation techniques as previously published 11 [ Fig.  1(c,d) ]. Both the nano-fibrous and solid-walled scaffolds had similar porosities of 96% (calculated from scaffold mass, dimensions, and crystallinity using a published protocol 6 ) and macro-porous structures.
Protein adsorption from serum to the scaffolds
Both scaffolds were incubated in human or bovine serum after they were completely wetted. The nanofibrous scaffold adsorbed 4.2-fold greater amount of human serum proteins than the solid-walled scaffold [ Fig.  2(A) ]. Consistent results were obtained from bovine serum. SDS-PAGE analysis corroborated that greater amounts of serum proteins were adsorbed to the nanofibrous scaffold [ Fig. 2(B) ]. Moreover, the profile of adsorbed serum proteins to the nano-fibrous scaffold was different from that to the solid-walled scaffold. Whereas the intensities of the protein with an approximate size of 150 kDa (arrow) adsorbed to both scaffolds similarly, the proteins with approximate sizes of 120, 45, or 40 kDa (arrowheads) exclusively adsorbed onto the nano-fibrous scaffold. Based on the measurements of band intensities of proteins, the amounts of proteins adsorbed to nano-fibrous scaffolds were 0.57-13.35 times those of corresponding proteins (bands) in control serum, whereas the amounts of proteins adsorbed to solidwalled scaffolds were 0.24 -0.79 times those of corresponding proteins in the control serum [ Table I and Fig.  2(C) ]. The ratios of adsorbed amounts of proteins on nano-fibrous scaffolds to those on solid-wall scaffolds were always Ͼ1.0 and varied drastically with the proteins ( Table I ). Considering that both scaffolds were made of the same PLLA material, it was surprising that nano-fibrous architecture alone could alter the profile of protein adsorption from serum and showed selectivity. More interestingly, Western blot analyses showed that the nano-fibrous scaffolds adsorbed large amounts of fibronectin and vitronectin from serum, but these celladhesion proteins were barely detected on the solidwalled scaffolds (Fig. 3) . These findings suggested that nano-fibrous scaffolds might have certain features enhancing specific protein-affinity and binding strength.
Adsorption of ECM proteins to the scaffolds
Cell-ECM interactions participate directly in mediating cell adhesion, migration, growth, differentiation, and apoptosis. 12 Adsorption of a few ECM proteins to nano-fibrous and solid-walled scaffolds was analyzed to understand the cell behavior on these different scaffolds. Prewetted scaffolds were incubated in fibronectin, vitronectin, laminin, or bovine serum albumin solution. These proteins were adsorbed to the nanofibrous scaffolds 2.6 -3.9 times higher than to the solid-walled scaffolds (Fig. 4) . The amounts of different ECM proteins adsorbed to the nano-fibrous scaffolds were statistically different among most of the ECM proteins studied (fibronectin, vitronectin, laminin, and albumin), with an exception that adsorbed amounts of vitronectin and albumin were similar. In contrast, the amounts of these proteins adsorbed to the solidwalled scaffolds were not statistically different. These features were consistent with the findings from serum protein adsorption, suggesting that nano-fibrous scaffolds have higher specificity for protein adsorption.
Cell attachment to the scaffolds
In tissue engineering, cell adhesion to a substrate is critical because adhesion precedes other events such as cell spreading, cell migration, and often, differentiated cell function. The nano-scaffolds were evaluated for cell attachment. After 24 h of cell seeding on scaffolds pretreated in fetal bovine serum, the amount of DNAs within a nano-fibrous scaffold was 1.7-fold of that within a solid-walled scaffold (Fig. 5) . Considering that both scaffolds (nano-fibrous and solid-walled) have the same macropore structure (interconnected spherical network) for cell accommodation, this finding suggests that nano-fibrous architecture provides a more favorable environment for cell attachment.
DISCUSSION
Tissues are made up of cells and ECM. During tissue development, ECM is secreted and organized locally by the cells. The ECM serves as a structural support for cells in the tissue. Also, cell-ECM interactions can directly control cell behavior such as attachment, migration, proliferation, differentiation, and ap- optosis, modulate the activities of cytokines and growth factors, and activate intracellular signaling. 12 Thus, cell-scaffold (artificial ECM) interactions are one of the most important issues for tissue-engineering applications. There has been very active research on the effects of chemical modification or surface morphology of materials on cell behavior. 13, 14 Certain bioactive peptides such as RGD-modified surfaces of polymer or other materials can enhance cell adhesion in serum-free culture medium. 15, 16 The cell behavior on surfaces with edges, grooves, or other textures is different from cell behavior on smooth surfaces. 14, 17 However, these modifications did not exceed the 2D concept: cells are only attached and interact with a material surface on one side. Considering that the cell in vivo contacts and communicates with ECM in three dimensions, the 3D structure is critical for scaffolds in tissue engineering. Here, we have demonstrated for the first time that the nano-fibrous scaffolding architecture (also having a high porosity and interconnectivity between pores) enhances protein adsorption and selectivity to certain proteins contributing to cell attachment.
We have also shown that the amount of proteins adsorbed to nano-fibrous scaffolds was much greater than that to solid-walled scaffolds. Higher surface-to- volume ratio of nano-fibrous scaffolds 10 may contribute to enhanced protein adsorption. Interestingly, the nano-fibrous scaffolds adsorbed a different profile of proteins from that seen in the solid-walled scaffolds, even though both scaffolds were made from the same PLLA material (Figs. 2 and 4) . More specific affinities of certain proteins to the nano-fibrous scaffolds suggest that the nano-fibrous architecture may act as a selective substrate, enhancing cell-ECM interactions. In addition to surface-to-volume ratio, the geometry of nano-fibers, the crystallinity, and orientation of the polymer could affect the affinities of proteins. All these factors possibly work together in enhancing protein adsorption and the specificity to the nano-fibrous scaffolds.
The unique collagen amino acid sequence forms three coiled subunits, which wind around each other in a characteristic right-handed triple helix, forming a collagen molecule. These molecules pack together side-by-side to form fibrils, and are further bundled into collagen fibers varying in diameter from 50 to 500 nm. PLLA has been shown to crystallize into helical structures. 18 -20 The helices existing in the synthetic PLLA nano-fibers may mimic collagen on a molecular level, and may explain in part the protein adsorption specificity and enhanced cell attachment.
Most tissue-derived cells are anchorage dependent and require attachment to a solid substrate for viability and growth. For this reason, the initial events that occur when a cell approaches a substrate are of fundamental interest. We showed that nano-fibrous scaffolds enhanced cell attachment 1.7-fold. The histology revealed that the cells adhered on the spherical macropore walls in the scaffolds (data not shown). This result indicates that both scaffolds, solid-walled and nano-fibrous, appear to have similar capacity at the macro and micro scales for cell accommodation even though the nano-fibrous scaffolds have higher surface area at the nanometer scale. Thus, it appears that the nano-fibrous scaffolds provide a more favorable environment for cells because of the nano-scaled features. As mentioned earlier, the cell behaviors appear to be secondary to adsorption of cell attachment proteins. The nano-fibrous architecture could increase the cell attachment to the scaffolds through better protein adsorption, including fibronectin and vitronectin, at least in part. In addition, nano-fibrous architecture could alter the mode of anchorage. Filopodia of the cells were reported to direct to certain particulate structure. 21 The nano-fibrous architecture could allow filopodia to anchor more tightly, and this mode of anchorage could also contribute to the adhesion strength to the nano-fibrous scaffolds. 
CONCLUSIONS
The newly developed nano-fibrous scaffolds adsorbed greater amounts and a more specific profile of proteins than the solid scaffolds. The nano-fibrous scaffolds also enhanced cell attachment. These findings suggest that nano-fibrous architecture in scaffolds provide a more favorable microenvironment for the cells, and support our hypothesis that nano-structured synthetic scaffolding could mimic the cell-ECM microenvironment.
